Learn more about how Mayo Clinic Laboratories’ testing can assist in diagnosis and differentiation of porphyrias and help guide treatment decisions
Browse our full menu of testing for motor and sensory neuropathies, spastic paraplegia, amyloidosis, and brachial plexus, among other conditions.
Organic acid disorders - Insights
Check out how Mayo Clinic Laboratories testing for organic acid metabolism disorders can help provide early diagnosis that enable prompt intervention.
Amino acid disorders - Insights
Learn more about how amino acid metabolism testing at Mayo Clinic Laboratories can assist in diagnosing the most preventable and treatable amino acid disorders.
Cardiovascular Pathology Services at Mayo Clinic Laboratories
Cardiovascular pathology focuses on a multidisciplinary approach to the consultative practice. Learn more about our service.
Effective testing is vitally important for diagnosis, prognosis, and disease management. With more than 90% of the 7,000 identified rare diseases lacking FDA-approved treatment,1 and patients waiting between 8 and 10 years before diagnosis,...
Mayo Clinic Laboratories’ BioPharma Diagnostics team facilitates customized collaborations with diagnostic companies to support their clinical and research testing needs.
Monogenic IBD Testing - Mayo Clinic Laboratories
Monogenic inflammatory bowel disease (IBD) refers to a diverse spectrum of rare genetic disorders that present with intestinal inflammation. The majority of patients with monogenic IBD, unlike those with polygenic IBD, show symptoms before...
Confirmatory testing - Insights
Use of mass spectrometry technology in Mayo Clinic Laboratories’ confirmatory drug testing enables accurate identification of parent drugs and metabolites, equipping providers with confidence about their patients’ drug use.
Hereditary causes of kidney stones - Insights
Learn about our kidney stone panel, which assesses 72 genes associated with inherited conditions that can lead to stone development.
Outreach Quality and Satisfaction - The Patient's View - Insights
As healthcare continues to evolve and payment models become more inclusive of patient satisfaction measures, it is vitally important for laboratories to focus on improving the patient experience. Because the laboratory is a critical element...
Jessica Wright, Pharm.D., BCACP, explains how Mayo Clinic Laboratories' 3A5Q test helps determine initial tacrolimus doses for individuals after non-liver organ transplants. Optimal tacrolimus levels are one of the important factors in...
Hereditary Oncology Testing [Test in Focus] - Insights
Wei Shen, Ph.D., explains Mayo Clinic Laboratories' new expert-backed, hereditary oncology panels, which use next-generation sequencing to identify genetic mutations linked to increased cancer risk. By only including clinically significant...
Newborn Screening at Mayo Clinic Laboratories
Newborn screening is intended to detect serious health conditions in babies for which early intervention can greatly improve healthy development and positive outcomes.
Own your lab, own your future - Insights
The laboratory is the cornerstone for health systems that offer complex care. Learn how lab ownership is a key driver of patient care excellence and health system growth.
New tests launched in November - Insights
In November 2022, Mayo Clinic Laboratories announced eighteen new tests along with numerous reference value changes, obsolete tests, and algorithm changes.
Novel panel identifies toxins linked to asthma and GI diseases - Insights
Melissa Snyder, Ph.D., explains how Mayo Clinic Laboratories' EDN panel improves the evaluation of certain patients with asthma and autoimmune digestive disorders. EDN is the first laboratory test that provides a marker of...
Chain of Custody Testing - Insights
Loralie Langman, Ph.D., explains the difference between chain of custody and clinical toxicology testing. Chain of custody is a process used for toxicology testing when the results might have legal implications for the individual tested....
Updated testing algorithms for plasma cell proliferative disorders [Test in Focus] - Insights
Xinjie Xu, Ph.D., co-director of Mayo's Genetics and Genomics Laboratory, explains Mayo Clinic Laboratories' updated approach to testing for risk stratification of patients newly diagnosed with plasma cell proliferative disorders, such as...
Liquid biopsy cancer testing - Insights
Learn how the pioneering approach used in liquid biopsy testing available through Mayo Clinic Laboratories enables individualized insights that drive personalized care.
Assay enhances and simplifies M-proteins screening: David Murray, M.D., Ph.D. - Insights
David Murray, M.D., Ph.D., explains how Mayo Clinic Laboratories' MASS-FIX Quantitation assay provides next-generation screening for M-proteins, which are associated with multiple myeloma and other diseases. The assay better quantitates the...
Clinical and forensic toxicology - Insights
Clinical, forensic, and emergency toxicology testing at Mayo Clinic Laboratories, which aligns with evidence-based clinical laboratory guidelines, uses advanced and emerging technologies and is performed on urine, serum, and meconium...
Neurofascin 155 IgG4 Antibody Test [Test in Focus] - Insights
John Mills, Ph.D., explains Mayo Clinic Laboratories' new neurofascin 155 (NF155) IgG4 antibody test, which is the first commercially available test in the U.S. to use flow cytometry to detect for NF155 antibodies and confirm diagnosis of...
Mayo Clinic and National Decision Support Company unveil CareSelect Lab™ to provide real-time medical guidance when ordering clinical lab tests. The tool assists health care providers with appropriate ordering of lab testing, improving...
Autoimmune Myelopathy Testing - Mayo Clinic Laboratories
Mayo Clinic Laboratories is the only laboratory in the world to offer testing for a novel form of autoimmune meningoencephalomyelitis.
We offer next-generation sequencing and comprehensive fluorescence in situ hybridization (FISH) panels, as well as extensive immunohistochemistry (IHC) offerings, to diagnose and monitor T-cell lymphoma.
Learn about our comprehensive MayoComplete solid tumor panel, which analyzes 515 genes for mutations, rearrangements, and amplifications.
Lung Cancer NGS Panel - Mayo Clinic Laboratories
Our targeted lung cancer panel assesses for mutations in eight genes, and rearrangements in four genes, including those recommended by the National Comprehensive Cancer Network: EGFR, ROS1, BRAF, and ALK.
Browse our menu of MayoComplete next-generation sequencing assays which are designed to identify a growing list of hematological cancers.
Thrombotic microangiopathy (TMA) - Insights
View our comprehensive testing suite designed to confirm diagnosis and facilitate treatment of thrombotic microangiopathy.
Chromosomal microarray - Insights
Learn how our microarray evaluations identify, analyze, and assess clinically significant chromosomal abnormalities.
Hereditary epilepsy - Insights
Find out how we perform in-depth mutation and copy number variant analysis to determine causes of epilepsy and identify potential treatment options.
Bobbi Pritt, M.D., Comments on Blacklegged Ticks in Minnesota Conservation Volunteer - Insights
Blacklegged ticks (also known as deer ticks) are turning up more frequently in Minnesota, and so are the diseases they carry. Bobbi Pritt, a parasitologist in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester,...
Find out how our streamlined approach to fluorescence in situ hybridization testing can simplify the ordering process and better meet patient needs.
New Year's Specimen Shipping Guidelines and Schedule - Insights
Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered for the New Year's holiday. To ensure specimen viability and minimize delays, the following adjustments and guidelines have been implemented and will be...
Mayo Clinic researchers identify new disease subtype linked to recurrent blood clots - Insights
Mayo Clinic researchers identify a new subtype of MGTS, linked to recurrent blood clots, with significant diagnostic challenges and treatment implications.
Christmas and New Year's specimen shipment alert - Insights
Due to the Christmas and New Year's holiday's (recognized on Sunday, December 25th, and Sunday, January 1st ), Mayo Clinic Laboratories' specimen pickup and delivery schedules will be altered. To ensure that your specimen vitality and...
Thanksgiving Holiday Shipment Schedules - Insights
The United States will observe the Thanksgiving holiday on Thursday, Nov. 23. On this day, Mayo Clinic Laboratories will be open; however, specimen shipments and deliveries to our laboratories will not be made by the carriers. To safeguard...
Testing Archives - Page 25 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
New Tests Launched Archives - Page 5 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
Top 5 Mayo Clinic Laboratories advancements in 2024 - Insights
Five of the most significant advancements from Mayo Clinic Laboratories in 2024 to enhance diagnostics and patient care globally.
Making the Promise of AI a Reality in Laboratory Medicine and Pathology - Insights
Register now – June 26, 2025 PACE / State of FLThis webinar explores how artificial intelligence (AI) and digital pathology have the potential to revolutionize the clinical laboratory landscape. These technologies are transforming...
Dr. Dong Chen and Dr. Sounak Gupta joined the “Becker’s Healthcare Podcast” to discuss the molecular testing space and its important role in personalized cancer treatment. Dr. Chen and Dr. Gupta highlighted the importance of selecting the...
New Tests Launched Archives - Insights
Skip to Content MayoACCESS MayoLINK...
New Tests Launched Archives - Page 2 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
New Tests Launched Archives - Page 3 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
New Tests Launched Archives - Page 4 of 6 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 13 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Christmas Holiday Shipment Schedules - Insights
The United States will observe the Christmas holiday on Monday, Dec. 25. On this day, Mayo Clinic Laboratories will be open; however, specimen shipments and deliveries to our laboratories will not be made by the carriers. To safeguard...
Gastrointestinal Pathology Service at Mayo Clinic Laboratories
In our practice, we review both luminal GI tract specimens and solid viscera. We cover the spectrum of pathology from routine to highly esoteric.